我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

胱抑素C和心血管疾病危险因素的关系

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第2期
页码:
250-253
栏目:
综述
出版日期:
2013-04-25

文章信息/Info

Title:
Cystatin C and cardiovascular risks
作者:
陈俊华; 李孝华
(武警新疆总队医院高血压科，武警 乌鲁木齐 830000)
Author(s):
CHEN Jun-hua;  LI Xiao-hua
(Department of Hypertension, Hospital of Xinjiang Armed Police Corps, Urümqi 830063, Xinjiang, China)
关键词:
胱抑素C; 心血管疾病; 危险因素
Keywords:
cystatin C;  cardiovascular disease;  atherosclerosis
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
半胱氨酸蛋白酶抑制剂（简称胱抑素C）是评价肾小球功能-肾小球滤过率最理想的指标之一。目前发现，胱抑素C与心血管疾病的发生及预后有密切关系。现就胱抑素C与心血管疾病危险关系的相关性做以下综述。
Abstract:
Cystatin C has been proposed as a good indicator of assessing renal function glomerular filtration rate (GFR). Patients with higher circulating cystatin C concentrations appear to have an increased cardiovascular risk profile. This report presents a review of the role of cystatin C as a predictor of cardiovascular risks.

参考文献/References

[1]Suzuki Y,Matsushita K,Yoshida T,et al.Clinical validity of renal function markers including serum cystatinC on chronic kidney disease classificatio[J].Rinsho Byori,2011,59(4):345-351.
[2]Coresh J,Selvin E,Stevens LA,et al.Prevalence of chronic kidney disease in the united states[J].JAMA,2007,298(17):2038-2047.
[3]Zahran A,Qureshi M,Shoker A.Comparision between creatinine and cystatin C-based GFR equations in renal transplantation[J].Nephrol Dial Transplant, 2007,22(9):2657-2668.
[4]Barka T,van der Noen H.Expression of the cysteine proteinase inhibitor cystatin C gene in rat heart:use of digoxigenin labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations[J].J Histochem Cytochem,1993,41(12):1863-1867.
[5]Parikh NI,Hwang SJ,Yang Q,et al.Clinical correlates and heritability of cystatin C(from the Framingham Offspring Study)[J].Am J Cardiol,2008,102(9):1194-1198.
[6]Muntner P,Mann D,Winston J,et al.Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease[J].Am J Cardiol,2008,102(1):54-57.
[7]Kestenbaum B,Rudser KD,de Boer IH,et al.Differences in kidney function and incident hypertension:the multiethnic study of atherosclerosis[J].Ann intern Med,2008,148(7):501-508.
[8]葛长江,任 芳,吕树铮,等.血浆胱抑素C对冠心病的临床预测价值[J].中华急诊医学杂志,2010,19(3):273-276.
[9]刘玉胜,鹿庆华,蒋卫东.血清组织蛋白酶S、胱抑素C水平与冠状动脉粥样硬化病变严重程度相关性的研究—附107例报道[J].新医学,2008,39(4):219-221.
[10]王超权,徐 耕,程 刚.血清胱抑素C水平对缺血性心力衰竭患者近期预后的影响[J].中国循环杂志,2009,24(1):29-31.
[11]Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystain C in acute heart failure in relation to othermarkers of renal function and NT2 pro BNP[J].Eur Heart J,2007,28(15):811-817.
[12]Ix JH,Shlipak MG,Chertow GM,et al.Association of Cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heartdisease: data from the Heart and Soul Study[J].Circulation,2007,115(2):173-179.

备注/Memo

备注/Memo:
收稿日期：2012-06-24.作者简介：陈俊华，主治医生，硕士 Email：chenjunhua169@163.com
更新日期/Last Update: 2013-04-28